Journal of Pharmaceutical & Biomedical Sciences
Peer-reviewed research across pharmaceutical sciences, biomedical sciences, translational medicine, drug discovery, pharmacology and biotechnology.
Slide 1 of 3: Advancing pharmaceutical and biomedical research
A peer-reviewed scientific journal focused on pharmaceutical formulation, drug delivery, pharmaceutical technology and biopharmaceutics, with particular emphasis on how these areas affect biological and therapeutic performance.
The journal seeks research that goes beyond characterisation of a formulation and shows how pharmaceutical design influences drug stability, solubility, dissolution, permeability, bioavailability, targeting, pharmacokinetics, efficacy, safety or other clinically relevant properties.
Record counts are verified. Editorial timings appear once published.
Research published to the journal record, newest first.
DOI pending registration
Model-based analysis of dosing exposure in an intensive care cohort, with covariate testing for renal function and body composition.
Editor's pick
DOI pending registration
A structured review of the formulation, toxicology and regulatory steps that separate a promising RNA construct from an approved medicine.
Editor's pick
DOI pending registration
Describes a reproducible interpretation pipeline and reports its concordance against curated reference calls.
DOI pending registration
Argues that formulation papers should deposit protocols at a level that another laboratory can run, not merely describe the intention of the method.
Volume 1, Issue 1 opens the journal record on 1 January 2027.
The inaugural issue opens the journal with research across pharmaceutical and biomedical sciences. The cover you see here is the Volume 1, Issue 1 identity; the issue itself will appear on the public record on 1 January 2027.
Chosen by the editors, not by an algorithm. One article is promoted at a time.
DOI pending registration
A comparative preclinical study evaluating formulation stability, cellular uptake and pharmacokinetic behaviour across three resistant tumour models.
The journal's subject taxonomy. Counts reflect records currently in the journal.
Focused collections addressing timely questions in pharmaceutical and biomedical science.
A focused issue on assay design, model-informed dosing and the clinical use of therapeutic drug monitoring. Articles will appear online as they are accepted.
View call for papersAccepted and copy-edited manuscripts, citable from the date they appear online and assigned to an issue later.
DOI pending registration · Toxicology
DOI pending registration · Medicinal Chemistry
DOI pending registration · Clinical Pharmacy
DOI pending registration · Biotechnology
These tables are driven by external citation and usage sources. Until those sources report, the journal shows nothing rather than an estimate.
Articles ranked by citations recorded against the published version.
No data to report yet
Citation counts appear once the journal is indexed by a citation database and the first records are matched.
Read the current issueArticles ranked by verified full-text views and downloads.
No data to report yet
Usage figures appear once COUNTER-compliant analytics are connected to the article record.
Read the current issueCalls for papers, special issues, editorial updates and events.
We invite original research and methods papers that connect preclinical pharmacology to early clinical investigation.
Guest editors are assembling a themed collection on carrier design, targeting strategies and controlled release.
An editorial session on experimental design, statistical reporting and the documentation reviewers look for.
Prof. Miriam Solberg
Placeholder institution — appointment pending · To be confirmed
The Editor-in-Chief sets the scientific standards of the journal, oversees the double-anonymised review process and chairs editorial decisions on scope, ethics and appeals. This profile is placeholder content held in the CMS until the appointment is announced.
Everything needed to judge fit, format a submission correctly and understand what happens after you submit.
Guidance for reviewers assessing pharmaceutical and biomedical research, including the standards we expect of a report.
Receive alerts about newly published research, new issues and journal announcements. We use your address for journal alerts only.
